 | Up a level |
2022
Henes, J., Saur, S., Kofler, D. M., Kedor, C., Meisner, C., Krusche, M., Koetter, I., Xenitidis, T., Schulze-Koops, H. and Feist, E. (2022). TOCILIZUMAB SIGNIFICANTLY REDUCES SERUM AMYLOID A IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER - DATA FROM THE PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND TOFFIFE STUDY. Ann. Rheum. Dis., 81. S. 30 - 32. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060
2018
Elhai, M., Distler, O., Smith, V., Matucci-Cerinic, M., Alegre-Sancho, J. J., Truchetet, M. -E., Braun-Moscovici, Y., Iannone, F., Chotchaeva, F., Lescoat, A., Siegert, E., Castellvi, I., Airo, P., Vettori, S., Hachulla, E., Erler, A., Ananieva, L., Krusche, M., Lopez-Longo, F., Distler, J., Hunzelmann, N., Hoffmann-Vold, A. -M., Riccieri, V., Hsu, V., Pozzi, M., Ancuta, C., Rosato, E., Mihai, C., Kuwana, M. and Allanore, Y. (2018). RITUXIMAB IN SYSTEMIC SCLEROSIS : SAFETY AND EFFICACY DATA FROM THE EUSTAR NETWORK. Ann. Rheum. Dis., 77. S. 122 - 123. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060